Status: Recruiting
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Data on the real-world use and effectiveness and safety of bempedoic acid combined with both a statin and ezetimibe in clinical practice is limited. There is an increased focus on using combination therapy to lower LDL-C.
Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyUpdated: Jun 11, 2026Locations: 163
Eligibility criteria
Written informed consent to participate [+6]
Patients who have received PCSK9i monoclonal antibody treatment in the last 3 mo... [+1]